"10.1371_journal.pone.0086048","plos one","2014-01-20T00:00:00Z","Nikolaus R McFarland; Hemi Dimant; Laura Kibuuka; Darius Ebrahimi-Fakhari; Cody A Desjardins; Karin M Danzer; Michael Danzer; Zhanyun Fan; Michael A Schwarzschild; Warren Hirst; Pamela J McLean","Center for Translational Research in Neurodegenerative Disease, Department of Neurology, University of Florida, Gainesville, Florida, United States of America; MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America; Division of Neurology and Inherited Metabolic Diseases, Childrens Hospital, Heidelberg University Hospital, Ruprecht-Karls University Heidelberg, Heidelberg, Germany; Deparment of Neurology, Universitatsklinikum Ulm, Ulm, Germany; Pfizer Neuroscience Research Unit, Cambridge, Massachusetts, United States of America; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, United States of America","Conceived and designed the experiments: NRM HD PJM. Performed the experiments: NRM HD LK DEF KMD MD. Analyzed the data: NRM HD LK DEF PJM. Contributed reagents/materials/analysis tools: ZF CAD MAS WH. Wrote the paper: NRM HD PJM.","Warren Hirst is employed by Pfizer Neuroscience. He helped provide the drugs for this study which are covered by Pfizer patents: WO 2008130879 (PF-04928473), WO 2006091963(PF-04924868) and WO 2008024977 (PF-04944733). There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","01","Nikolaus R McFarland","NRMF",11,TRUE,3,6,5,3,TRUE,TRUE,FALSE,0,NA,FALSE
